
FDA Stops Sales of Generic Ozempic and Wegovy
Tens of thousands of individuals who depend on lower-cost, compounded forms of Ozempic and Wegovy, the two medicines used to manage Type 2 diabetes and for weight loss, may be impacted by the FDA’s recent landmark ruling. The active ingredient in each medication is semaglutide, and the generic versions of those medications have long been…